生物制药合同制造市场规模预计将从2024年的409.9亿美元增至2031年的1010.5亿美元。预计2025年至2031年期间,该市场的复合年增长率将达到13.8%。先进制造技术正在成为生物制药合同制造市场的一个重要趋势。
生物制药合同制造市场分析
由于对单克隆抗体、基因疗法和疫苗等生物制剂的需求不断增长,生物制药合同制造市场正在经历大幅增长,这需要专业的制造能力,促使制药公司将生产外包给合同制造组织 (CMO)。连续加工、一次性系统和自动化等制造技术的进步提高了生产效率和可扩展性,使 CMO 能够满足生物生产的复杂需求。外包倾向的日益增强使公司能够专注于核心竞争力,同时降低运营成本和资本支出。此外,新兴市场医疗保健覆盖面的扩大,加上有利的监管环境,为合同制造商服务更广泛的客户群提供了新的机会。生物制药公司与 CMO 之间的战略合作伙伴关系和联盟促进了技术转让和工艺优化,从而加快了产品开发和商业化进程。这些因素共同促进了全球生物制药合同制造市场的增长。
生物制药合同制造市场概况
由于对生物制剂、生物仿制药和复杂疗法的需求不断增长,全球生物制药合同制造市场正在加速发展。北美凭借强大的生物制药公司和监管支持引领市场。连续制造和机器人等技术进步正在提高生产过程的效率和可扩展性。此外,地缘政治变化促使企业实现供应链多元化,Syngene International 等印度公司正在美国扩大业务,以减轻依赖中国制造业带来的风险。同样,欧洲 CMO 正在扩大生物制剂、细胞和基因疗法以及高效 API 等高增长领域的能力。德国、法国和瑞士等国家凭借其完善的基础设施和创新驱动的生态系统继续保持领先地位,而包括波兰和匈牙利在内的中欧和东欧新兴中心则因成本优势和不断增长的技术专长而获得关注。战略伙伴关系、监管协调以及政府支持政策使欧洲成为端到端生物制药制造服务的多元化和竞争性地区。
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
生物制药合同制造市场:

- 获取此报告的顶级关键市场趋势。此免费样品将包括数据分析,从市场趋势到估计和预测。
生物制药合同制造市场驱动因素和机遇
生物制剂需求增长推动市场
生物制剂是现代医学的基础,因为它们在治疗癌症、自身免疫性疾病和遗传疾病等复杂慢性疾病方面疗效显著。单克隆抗体、疫苗、细胞和基因疗法以及重组蛋白是医疗服务中广泛使用的一些主要生物制剂。根据美国国家癌症研究所的数据,2022年报告的癌症新发病例约为2000万例,癌症相关死亡病例约为970万例。此类慢性疾病的增多催生了对生物制剂的需求,促使制药商与专门从事生物制剂生产的合同生产组织 (CMO) 加强合作。
生物制剂制造是一个复杂的过程,需要高度专业化的设备、专业知识和设施。由于生物制剂自建生产设施生产周期长、成本高昂,外包显得尤为重要。CMO 提供必要的基础设施和专业知识,以实现规模化生产,使药物开发商无需大量资本投入即可满足市场需求。罗氏和百时美施贵宝等制造商在 CMO 的帮助下开发了基于单克隆抗体的生物制剂赫赛汀和欧狄沃,从而彻底改变了癌症治疗。这些疗法显著增加了对合同制造服务的需求,因为企业正在寻求能够大规模生产这些高度复杂生物制剂的专业设施。因此,对生物制剂日益增长的需求催生了对专业化、经济高效且可扩展的生产解决方案的需求,从而推动了生物制药合同制造市场的增长。
个性化医疗需求不断增长,创造增长机会
个性化医疗通过提供针对个体患者独特基因特征、环境和生活方式的定制化治疗,提供了重要的机遇。随着基因组学、生物技术和诊断技术的进步,这种方法正被越来越多地采用,从而实现更精准、更有效的治疗。个性化医疗的不断发展催生了对专业化、灵活化和可扩展化生产解决方案的需求。这些发展也促进了与CMO的合作,以将这些疗法推向市场。个性化治疗通常需要定制化的方法,这需要更灵活的生产流程,包括基因疗法、细胞疗法和精准肿瘤治疗。因此,越来越多的生物制药公司开始寻求CMO的帮助,因为他们拥有专业知识和能力来满足这些专业的生产需求。
个性化医疗需求的日益增长,凸显了对高效、可扩展的制造流程的需求,这些流程能够适应高度个性化治疗的生产。例如,基因疗法 Kymriah(诺华公司开发)和 Yescarta(吉利德公司开发)就是已成功开发并商业化的个性化药物。拥有合适基础设施的 CMO 可以提供这些治疗方案,因为它们需要独特的制造流程。此外,能够提供细胞疗法或基因编辑技术(例如基于 CRISPR 的疗法)生产专业服务的 CMO 更有能力从个性化医疗趋势中获益。随着企业向更小批量、更灵活和更定制化的方向发展,CMO 在确保这些治疗方案高效且经济地生产方面发挥着至关重要的作用,从而在预测期内为市场创造丰厚的利润机会。
生物制药合同制造市场报告细分分析
生物制药合同制造市场分析的基础关键部分是产品类型、来源、应用和治疗领域。
- 根据产品类型,生物制药合同制造市场分为生物制剂和生物仿制药。2024年,生物制剂市场将占据更大的份额。
- 从来源来看,生物制药合同制造市场分为微生物和哺乳动物两类。2024年,微生物领域占据市场主导地位。
- 根据应用,生物制药合同制造市场分为商业和临床。2024年,商业领域占据了更大的市场份额。
- 按治疗领域划分,市场分为肿瘤科、自身免疫性疾病、呼吸系统疾病、代谢性疾病、神经科、传染病及其他。2024年,肿瘤科占据了生物制药合同制造市场份额的主导地位。
生物制药合同制造市场份额(按地区)分析
生物制药合同制造市场报告的地理范围分为五个区域:北美、亚太、欧洲、中东和非洲以及南美和中美。
2024年,北美占据了相当大的市场份额。北美全球生物制药合同制造市场的增长得益于其成熟的制药行业、先进的技术基础设施以及支持创新和高质量制造的强大监管框架。美国凭借其庞大的制药基地、高额的研发投入以及重要的合同开发和制造组织(CDMO)的存在,仍然占据主导地位。加拿大也在拓展其能力,尤其是在利基生物制剂和无菌制造领域。制药公司外包趋势的增长降低了成本并加快了产品上市时间,进一步推动了该地区生物制药合同制造市场的发展。
生物制药合同制造市场区域洞察
Insight Partners 的分析师已详尽阐述了预测期内影响生物制药合同制造市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的生物制药合同制造市场细分和地域分布。

- 获取生物制药合同制造市场的区域特定数据
生物制药合同制造市场报告范围
报告属性 | 细节 |
---|---|
2024年的市场规模 | 409.9亿美元 |
2031年的市场规模 | 1010.5亿美元 |
全球复合年增长率(2025-2031) | 13.8% |
史料 | 2021-2023 |
预测期 | 2025-2031 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
生物制药合同制造市场参与者密度:了解其对业务动态的影响
生物制药合同制造市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的演变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。
市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。
在生物制药合同制造市场运营的主要公司有:
- 勃林格殷格翰国际有限公司
- 赛默飞世尔科技公司
- 龙沙集团
- 默克公司
- 艾伯维公司
- 通用电气公司
免责声明:以上列出的公司没有按照任何特定顺序排列。

- 获取生物制药合同制造市场顶级关键参与者概述
生物制药合同制造市场新闻和最新发展
生物制药合同制造市场评估是通过收集一手资料和二手资料后进行的定性和定量数据进行的,这些数据包括重要的企业出版物、协会数据和数据库。市场的一个关键发展如下:
- 龙沙完成对罗氏位于美国瓦卡维尔的大型生物制剂生产基地的收购。(来源:龙沙,新闻稿,2024年10月)
- Sutro Biopharma 与勃林格殷格翰 BioXcellence 合作:在商业规模上建立一流的无细胞生产能力。(来源:Sutro Biopharma, Inc.;新闻稿,2025 年 1 月)
- 勃林格殷格翰强化其在中国的生物制药合同生产服务。(来源:勃林格殷格翰国际有限公司,新闻稿,2025年3月)
生物制药合同制造市场报告覆盖范围和交付成果
《生物制药合同制造市场规模和预测(2021-2031)》报告对以下领域进行了详细的市场分析:
- 生物制药合同制造市场规模以及本范围涵盖的所有关键细分市场的全球、区域和国家层面的预测
- 生物制药合同制造市场趋势和市场动态,例如驱动因素、限制因素和关键机遇
- 详细的 PEST 和 SWOT 分析
- 生物制药合同制造市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及生物制药合同制造市场的最新发展
- 详细的公司简介
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集


- Single Pair Ethernet Market
- Sleep Apnea Diagnostics Market
- Adaptive Traffic Control System Market
- Online Exam Proctoring Market
- UV Curing System Market
- Cosmetic Bioactive Ingredients Market
- Dairy Flavors Market
- Cell Line Development Market
- Authentication and Brand Protection Market
- Ceiling Fans Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
North America dominated the market in 2024.
Rising demand for biologics and increasing demand for cost efficiency and flexibility contribute to market growth.
Boehringer Ingelheim International GmbH, Thermo Fisher Scientific Inc., Lonza Group AG, Merck KGaA, AbbVie Inc., General Electric Co, Samsung Biologics Co Ltd, WuXi Biologics Inc., Inno Bio Ventures Sdn Bhd, and Ajinomoto Co Inc. are among the key players operating in the biopharmaceutical contract manufacturing market.
The market is estimated to register a CAGR of 13.8% during the forecast period.
The market is expected to reach a value of US$ 101.05 billion by 2031.
The List of Companies - Biopharmaceutical Contract Manufacturing Market
- Boehringer Ingelheim International GmbH
- Thermo Fisher Scientific Inc
- Lonza Group AG
- Merck KGaA
- AbbVie Inc.
- General Electric Co
- Samsung Biologics Co Ltd
- WuXi Biologics Inc
- Inno Bio Ventures Sdn Bhd
- Ajinomoto Co Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.